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A B S T R A C T
Objective: This study aims to investigate factors associated with the self-reported need for treatment of
sleeping diﬃculties in the general population.
Methods: This study consisted of a cross-sectional telephone survey of 1550 people randomly selected
from the total population of Sweden. The survey, conducted by the Swedish national statistics agency,
Statistics Sweden, was completed by 1115 people aged 18–85 years. Participants were asked about sleep
patterns, daytime symptoms, physical and mental health disorders, use of prescribed hypnotics, help-
seeking behaviors, and sociodemographic characteristics. They were also asked whether they thought
they needed treatment for sleeping diﬃculties.
Results: A total of 12.5% of the participants reported a need for treatment because of sleeping diﬃcul-
ties. Signiﬁcantly more women than men reported such a need (OR 1.46, 95% CI 1.02–2.10). Additionally,
in univariate analyses, older age (age 60–69), sick leave, retirement, and unemployment were associ-
ated with a self-reported need for treatment, as were several sleep complaints, daytime symptoms, and
physical and mental health disorders. A logistic regression model showed that diﬃculty initiating sleep
(OR 6.29, 95% CI 3.67–10.78) was the factor most strongly associated with a self-reported need for treat-
ment for sleeping diﬃculties. Other important factors were nonrestorative sleep (OR 3.70, 95% CI 2.05–
6.69), mental health disorders (OR 3.01, 95% CI 1.59–5.67), and fatigue (OR 2.95, 95% CI 1.53–5.68).
Conclusions: There was considerable self-reported need for treatment for sleeping diﬃculties in the pop-
ulation. Diﬃculty initiating sleep was the factor most strongly associated with this need, followed by
nonrestorative sleep, mental health disorders, and fatigue.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Sleeping diﬃculties are a prevalent health concern. About 20–
30% of the adult population worldwide report diﬃculty initiating
or maintaining sleep [1–3]. Women are more likely to report such
diﬃculties than men [4].
Sleepingdiﬃculties increase the risk for several serioushealth con-
ditions, including cardiovascular disease, diabetes, andmental health
disorders [5–7]. Peoplewith sleep-related conditions havemore fre-
quent contactwith healthcare providers for both somatic andmental
health disorders than those without sleeping diﬃculties [2,8–12].
Although there is high prevalence of sleeping diﬃculties in the
global population and effective treatments exist, a large number of
people do not seek treatment for these diﬃculties [2,13–16]. Possi-
ble barriers to seeking help include self-medication with over-the-
counter drugs or alcohol and a lack of understanding of available
treatments [13]. People also tend to perceive their sleep problems as
benign and trivial, and something they should be able to cope with
[17].
Previous studies have focused on the characteristics of those who
seek help from healthcare providers for their sleeping problems. Few
have examined sleeping diﬃculties in the population as a whole.
Thus, little is known about the group of people who do not seek
help for their sleeping diﬃculties and even less is known about their
perceived need for treatment.
The unique Scandinavian system of population-level data, which
covers all resident individuals in these countries, provided the op-
portunity to conduct a survey of sleeping diﬃculties in a random
sample of the general Swedish population. This study aimed to
investigate factors associated with self-reported need for treat-
ment of sleeping diﬃculties. The characteristics and symptoms
of people who said that they needed treatment for sleeping
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diﬃculties in the survey were compared with those who said they
did not.
2. Methods
2.1. Data collection
This study analyzed data from a nationwide, randomized tele-
phone survey that the Swedish Council on Health Technology
Assessment initiated to investigate sleeping diﬃculties in the
Swedish population. The survey was conducted in December 2008
by Statistics Sweden, the country’s oﬃcial government statistics
agency. The agency selected a random representative sample of the
Swedish population using the Swedish Population Register. The
sample was proportionally stratiﬁed by sex. A week before the start
of the survey, Statistics Sweden sent a letter with information about
the content and aim of the survey to the participants. The phone
numbers of the people in the sample were collected from a tele-
communication agency and trained interviewers from Statistics
Sweden performed computer-assisted phone calls to collect the data.
2.1.1. Sample
The sample consisted of 1550 randomly selected people aged
18–94 years from the Swedish population. 1128 people (72.8% of
the sample) completed the telephone survey.
Of those who completed the survey, 1115 (98.8% of the 1128 par-
ticipants) responded to the outcome question: “Do you think you
need treatment of some kind for sleeping diﬃculties?” The answers
to this question were used to construct the outcome variable in this
study (see Section 2.1.2.1 below). All analyses were based on data
from the 1115 people who responded to this question. The respon-
dents were aged 18–84 years old; their mean age was 49.4 years
(SD 17.7), 532 (47.7 %) were men, and 583 (52.3%) were women. The
characteristics of the 1115 participants are presented in Table 1.
A total of 422 in the total sample (27. 2%) did not participate in
the telephone survey. Of those who did not participate, 233 (55.2%)
were men and 189 (44.8%) were women, 217 (51.4%) were unreach-
able, 162 (38.4%) declined to participate, and 43 (10.2%) were not
able to participate for unspeciﬁed reasons. Of the 13 participants
who did not respond to the outcome question, eight were men and
ﬁve were women; their mean age was 40.4 years (SD 11.8).
2.1.2. Material
The telephone survey included 39 questions about the need for
treatment, sociodemographic characteristics, sleep patterns, daytime
symptoms, physical and mental health disorders, help-seeking be-
havior, and use of prescribed hypnotics. The responses to the survey
questions were used to construct the following variables:
2.1.2.1. Self-reported need for treatment. The outcome variable in this
study was self-reported need for treatment of sleeping diﬃcul-
ties. The survey question to identify need for treatment was: “Do
you think you need treatment of some kind for sleeping diﬃcul-
ties?” Possible responses were yes or no.
2.1.2.2. Sociodemographic characteristics. For the purposes of anal-
ysis, participants were divided by sex, age group in years [18–29,
30–39, 40–49, 50–59, 60–69, and 70–84], employment status (em-
ployed, student, on sick leave, retired, unemployed, onparental leave),
and marital status (single/living alone and married/cohabiting).
2.1.2.3. Sleep complaints. Diﬃculty initiating sleep was assessed by
asking: “How often do you have diﬃculty falling asleep?” Early
morning awakening was assessed by asking: “How often have you
woken up too early in the morning and were not able to go back
to sleep?” Nonrestorative sleep was assessed by asking: “How often
does your sleep provide insuﬃcient rest?” The recall period for these
questions was the month prior to the study. Responses were given
on a 5-point scale that ranged from 1 (never or less than once a
month) to 5 (daily or almost daily). Responses were collapsed for
the current analyses: responses between 1 and 3 (never to twice a
week) were classiﬁed as indicating minor problems, and re-
sponses between 4 and 5 (three nights a week to daily) as major
problems.
Diﬃculty maintaining sleep was assessed by asking: ‘Howmany
times do you usually wake up at night?’ Responses were provided
on a 5-point scale that ranged from 1 (zero times) to 5 (at least ﬁve
times). Responses between 1 and 3 (zero to two times) were clas-
siﬁed as indicating minor problems, and responses between 4 and
5 (three or more times) as major problems.
A categorical variable was also created for analyzing sleep com-
plaints. The categories were one sleep complaint, two sleep
complaints, three sleep complaints, and four sleep complaints.
Sleeping diﬃculties of a more persistent nature were assessed
by asking: ‘During adulthood, how has your sleep been in general?’
Responses were provided on a scale of 1–5; higher scores indi-
cated worse problems. Responses between 1 and 3 (very good to
moderate) were classiﬁed as signifying minor problems, and re-
sponses between 4 and 5 (quite bad to very bad) as major problems.
2.1.2.4. Sleep duration and sleep onset latency. Sleep duration was
assessed with questions about estimated total hours of sleep on
weeknights and weekends. Sleep onset latency was assessed by
asking: “How many minutes does it usually take to fall asleep?”
Answers were treated as continuous variables.
2.1.2.5. Daytime symptoms. All the questions about daytime symp-
toms had a recall period of one month and were assessed by asking:
‘Have you had problems with daytime fatigue?’, ‘Have you had dif-
ﬁculty concentrating?’, ‘Have you had problemswith becoming easily
irritated?’, and ‘Have you had problems with depressedmood?’ Pos-
sible answers were yes or no. If the participant answered yes, he
or she was asked about the severity of the problem. Responses to
the question about severity were provided on a 4-point scale that
ranged from 1 (minor problems) to 4 (very severe problems). Re-
sponses of 1–2 were classiﬁed as indicating minor problems, and
responses of 3–4 as major problems.
2.1.2.6. Interference with daily life. To assess more comprehensive
problems related to sleeping diﬃculties, the participants were asked
two questions. The ﬁrst was: ‘Have your sleeping diﬃculties inter-
fered with your daily life during the last month?’ Possible answers
were yes and no. If the participant answered yes, he or shewas asked
about the severity of the problem. Responses to the question about
severity were provided on a 4-point scale that ranged from 1 (minor
problems) to 4 (very severe problems). Responses of 1–2 were clas-
siﬁed as indicating minor problems, and responses of 3–4 as major
problems. The second question was: ‘To what extent are sleeping
diﬃculties a problem in your life?’ Responses were provided on a
scale of 1–5; higher scores indicated more severe problems. Re-
sponses between 1 and 3 were classiﬁed as signifying minor
problems, and responses of 4–5 as major problems.
2.1.2.7. Insomnia disorder. Insomnia disorder (according to Diag-
nostic and Statistical Manual of Mental Disorders, 5th edition) is
the presence, for at least 1 month or more, of at least one symptom
of disturbed sleep combined with daytime symptoms [18]. For the
purposes of the current analyses, insomnia disorder was deﬁned
as havingmajor diﬃculty initiating sleep during the past month and/
or maintaining sleep (score between four and ﬁve), and having
moderate to severe sleeping diﬃculties that interfered with daily
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life (score 2–4) during the past month. This variable was dichoto-
mized into no insomnia and insomnia.
2.1.2.8. Health. Physical and mental health disorders were as-
sessed with a yes-or-no question about each disorder that started
‘Do you have . . .’ The interviewer asked about joint pain, gastroin-
testinal disorder, depression, hypertension, asthma, heart disease,
urogenital disorder, diabetes, ﬁbromyalgia, cancer, psychiatric dis-
order, depression, and burnout. The responses to the yes-or-no
questions about psychiatric disorder, depression, and burnout were
used to create the variable: presence of any mental health disor-
ders. The variable was dichotomized into absence of these disorders
and presence of at least one of these disorders.
To assess self-rated health, the interviewer asked: ‘How do you
perceive your general health?’ Responses were provided on a 5-point
scale that ranged from 1 (very good) to 5 (very bad). Thosewho chose
1–3 were classiﬁed as having good general health, and those who
chose 4–5 as having poor general health.
2.1.2.9. Help-seeking behavior and use of prescribed
hypnotics. Help-seeking behavior was assessed by the yes-or-no
question: ‘Have you ever consulted a physician for sleeping diﬃ-
culties?’ Use of hypnotics was assessed by the question: ‘How often
during the last month have you used prescribed sleep medica-
tion?’ Responses were provided on a 5-point scale (1, never or less
than once a month; 2, less than once a week; 3, once or twice a
week; 4, three to ﬁve days a week; and 5, daily or almost daily).
For the purposes of the current analyses, a response of 1–2 on the
scale was considered less than weekly use, and a response of 3–5
on the scale as weekly use.
Table 1
Characteristics of the sample (For unadjusted values, see Table 2) (n = 1115).a
Variables Reported need for treatment
n = 139
Reported no need for treatment
n = 976
Total sample
1115
N (%) N (%) N (%) N (%) N (%)
Men
55 (39.6)
Women
84 (60.4)
Men
477 (48.9)
Women
499 (51.1)
Age group
18–29 12 (21.8) 9 (10.7) 103 (21.6) 96 (19.2) 220 (19.7)
30–39 8 (14.5) 8 (9.5) 92 (19.3) 80 (16.0) 188 (16.9)
40–49 9 (16.4) 18 (21.4) 75 (15.7) 90 (18.0) 192 (17.2)
50–59 6 (10.9) 15 (17.9) 72 (15.1) 75 (15.0) 168 (15.1)
60–69 14 (25.5) 19 (22.6) 80 (16.8) 82 (16.4) 195 (17.5)
70–84 6 (10.9) 15 (17.9) 55 (11.5) 76 (15.2) 152 (13.6)
Marital status
Single/Living alone 23 (4.8) 29 (34.5) 160 (33.5) 146 (29.3) 358 (32.1)
Married/Cohabiting 32 (58.2) 54 (64.3) 314 (65.8) 352 (70.5) 752 (67.4)
Employment status
Employed 27 (49.1) 27 (32.1) 325 (68.1) 278 (55.7) 627 (58.9)
Student 3 (5.5) 5 (6) 37 (7.8) 45 (9.0) 90 (8.1)
Sick leave 3 (5.5) 10 (11.9) 2 (0.4) 6 (1.2) 21 (1.9)
Retired 18 (32.7) 36 (42.9) 97 (20.3) 133 (26.7) 284 (25.5)
Unemployed 4 (7.3) 4 (4.8) 13 (2.7) 15 (3.0) 36 (3.2)
Parental leave 0 (0.0) 1 (1.2) 1 (0.2) 20 (4.0) 22 (2.0)
Sleep complaints
Diﬃculty initiating sleep 30 (54.5) 59 (70.2) 30 (6.3) 50 (10.0) 169 (15.2)
Early morning awakening 22 (40.7) 35 (42.2) 41 (8.6) 62 (12.4) 160 (14.3)
Diﬃculty maintaining sleep 20 (36.4) 40 (47.6) 42 (8.8) 68 (13.7) 170 (15.2)
Nonrestorative sleep 32 (58.2) 52 (64.2) 27 (5.7) 60 (12.1) 171 (15.3)
Daytime symptoms
Fatigue 21 (38.2) 40 (47.6) 9 (1.9) 49 (9.8) 119 (10,7)
Depressed mood 14 (25.5) 25 (30.1) 12 (2.5) 20 (4.0) 71 (6.4)
Easily irritated 14 (25.5) 18 (21.4) 10 (2.1) 18 (3.6) 60 (5.4)
Diﬃculty concentrating 11 (20.4) 23 (27.4) 12 (2.5) 8 (1.6) 54 (4.8)
Physical and mental disorders
Mental health disorders 21 (38.2) 44 (52.4) 27 (5.7) 53 (10.7) 145 (13.0)
Joint pain 18 (32.7) 46 (54.8) 79 (16.6) 123 (24.7) 266 (23.9)
Gastrointestinal disorder 24 (43.6) 29 (34.5) 61 (12.8) 101 (20.3) 215 (19.3)
Hypertension 18 (34) 22 (26.2) 48 (10.3) 85 (17.2) 173 (15.5)
Asthma 16 (29.1) 15 (17.9) 52 (10.9) 57 (11.4) 140 (12.6)
Heart disease 11 (20) 10 (11.9) 25 (5.3) 28 (5.6) 74 (6.6)
Urogenital disorder 9 (16.4) 12 (14.3) 27 (5.7) 24 (4.8) 72 (6.5)
Diabetes 8 (14.5) 7 (8.4) 27 (5.7) 20 (4.0) 62 (5.6)
Fibromyalgia 0 (0.0) 11 (13.1) 2 (0.4) 8 (1.6) 21 (1.9)
Cancer 2 (3.6) 5 (6.0) 15 (3.2) 9 (1.8) 31 (2.8)
Other variables
Insomnia disorder 21 (38.9) 50 (59.5) 14 (2.9) 29 (5.8) 114 (10.2)
Persistent sleeping diﬃculties 16 (29.1) 27 (32.1) 8 (1.7) 16 (3.2) 67 (6.0)
Sleeping diﬃculties interfere with daily life 20 (37.0) 33 (39.3) 6 (1.3) 10 (2.0) 69 (6.2)
Sleeping diﬃculties a major problem in life 20 (36.4) 48 (57.1) 2 (0.4) 11 (2.2) 81 (7.3)
Poor general health 13 (23.6) 21 (25.0) 11 (2.3) 12 (2.4) 57 (5.1)
Sleep duration weeknights in hours, mean (SD) 6.08 (SD 1.5) 5.63 (SD 1.5) 6.97 (SD 1.0) 7.14 (SD 1.1) 6.91 (SD 1.2)
Sleep duration weekends in hours, mean (SD) 6.96 (SD 2.2) 6.85 (SD 2.4) 7.96 (SD 1.4) 7.83 (SD 1.3) 7.77 (SD 1.5)
Sleep onset latency in minutes, mean (SD) 45.60 (SD 38.0) 64.92 (SD 65.5) 16.14 (SD 18.1) 19.80 (SD 25.8) 23.04 (SD 31.8)
Sleep onset latency in minutes, median 40 60 10 10 10
Abbreviations: SD, standard deviation.
a Self-reported need for treatment was ascertained by asking the yes-or-no question: ‘Do you think you need treatment of some kind for sleeping diﬃculties?’
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2.1.3. Statistical analysis
Analyses were performed with IBM SPSS (version 22, IBM Corp.,
Armonk, NY, USA).
Descriptive statistics (Table 1) were used to summarize the so-
ciodemographic characteristics of the study sample and to estimate
the proportion of explanatory variables in relation to the outcome
variable (need for treatment of sleeping diﬃculties: yes or no).
Univariate logistic regression with odds ratios (ORs) and 95% con-
ﬁdence intervals (CIs) were used to determine associations between
self-reported need for treatment and explanatory variables (Table 2).
Logistic regression models (Table 3) were constructed, which in-
cluded clinically relevant variables that were signiﬁcantly associated
with self-reported need for treatment in a univariate analysis. The
modeling was conducted in three steps to select variables in-
cluded in the ﬁnal logistic regression analysis. Model 1 included
speciﬁc sleep complaints. Daytime symptoms were added in Model
2, and physical and mental health disorders were added in Model
3. Variables not signiﬁcantly associated with need for treatment in
Model 1 were not included in Model 2, and variables not signiﬁ-
cantly associated with need for treatment in Model 2 were not
included in Model 3. All three models were adjusted for age and
sex. The Hosmer–Lemeshow goodness-of-ﬁt test was used to assess
whether the values predicted by themodel signiﬁcantly differed from
observed values (p > 0.05).
Analysis of variance (ANOVA) and the independent Student’s t-test
were used to analyze differences in sleep duration and the inde-
pendent Mann–Whitney U test was used to analyze differences in
sleep onset latency. Pearson’s chi-squared test was used to identi-
fy differences in proportions of people with insomnia who reported
no need for treatment and people with insomnia who reported need
for treatment (Fig. 2). The signiﬁcance level was 5% (two-tailed).
2.1.4. Ethical approval
Approval to use the survey data for this study was obtained from
the Regional Ethical Review Board in Stockholm, Sweden (Reg. no.
2014/256-31/5).
Table 2
Odds ratios (ORs) and 95% conﬁdence intervals (CIs) of the association between self-reported need for treatment of sleeping diﬃcultiesa and explanatory factors.
Explanatory factors Reported need for
treatment n = 139
Reported no need for
treatment n = 976
Univariate analyses
N (%) N (%) OR 95% CI
Sex
Male 55 (39.6) 477 (48.9) 1 (Reference)
Female 84 (60.4) 499 (51.1) 1.46 1.02–2.10
Age group
18–29 21 (15.1) 199 (20.4) 1 (Reference)
30–39 16 (11.5) 172 (17.6) 0.88 0.45–1.74
40–49 27 (19.4) 165 (16.9) 1.55 0.85–2.84
50–59 21 (15.1) 147 (15.1) 1.35 0.71–2.57
60–69 33 (23.7) 162 (16.6) 1.93 1.08–3.47
70–84 21 (15.1) 131 (13.4) 1.52 0.80–2.89
Marital status
Single/Living alone 52 (37.4) 306 (31.4) 1 (Reference)
Married/Cohabiting 86 (61.9) 666 (68.2) 0.76 0.53–1.10
Employment status
Employed 54 (38.8) 603 (61.8) 1 (Reference)
Student 8 (5.8) 82 (8.4) 1.09 0.50–2.37
Sick leave 13 (9.4) 8 (0.8) 18.15 7.21–45.70
Retired 54 (38.8) 230 (23.6) 2.62 1.75–3.94
Unemployed 8 (5.8) 28 (2.9) 3.19 1.39–7.34
Parental leave 1 (0.7) 21 (2.2) 0.53 0.07–4.03
Sleep complaints (yes vs no)
Diﬃculty initiating sleep 89 (64.0) 80 (8.2) 19.91 13.15–30.16
Early morning awakening 57 (41.0) 103 (10.6) 6.03 4.06–8.97
Diﬃculty maintaining sleep 60 (43.2) 110 (11.3) 5.97 4.04–8.81
Nonrestorative sleep 84 (60.4) 87 (8.9) 16.41 10.89–24.73
Daytime symptoms (yes vs no)
Fatigue 61 (43.9) 58 (5.9) 12.36 8.06–18.96
Depressed mood 39 (28.1) 32 (3.3) 11.58 6.95–19.32
Easily irritated 32 (23.0) 28 (2.9) 10.06 5.83–17.36
Diﬃculty concentrating 34 (24.5) 20 (2.0) 15.55 8.63–27.99
Physical and mental disorders (yes vs no)
Mental health disorders 65 (46.8) 80 (8.2) 9.79 6.54–14.67
Joint pain 64 (46.0) 202 (20.7) 3.26 2.26–4.71
Gastrointestinal disorder 53 (38.1) 162 (16.6) 3.09 2.11–4.53
Hypertension 40 (28.8) 133 (13.6) 2.56 1.70–3.87
Asthma 31 (22.3) 109 (11.2) 2.28 1.46–3.57
Heart disease 21 (15.1) 53 (5.4) 3.09 1.80–5.31
Urogenital disorder 21 (15.1) 51 (5.2) 3.22 1.87–5.55
Diabetes 15 (10.8) 47 (4.8) 2.41 1.31–4.44
Fibromyalgia 11 (7.9) 10 (1.0) 8.31 3.46–19.97
Cancer 7 (5.0) 24 (2.5) 2.10 0.89–4.97
Other variables (yes vs no)
Insomnia disorderb 71 (51.1) 43 (4.4) 22.97 14.61–36.12
Persistent sleeping diﬃculties 43 (30.9) 24 (2.5) 17.71 10.30–30.45
Sleeping diﬃculties interfere with daily life 53 (38.1) 16 (1.6) 37.41 20.50–68.27
Sleeping diﬃculties a major problem in lifeb 68 (48.9) 13 (1.3) 70.87 37.36–134.46
Poor general health 34 (24.5) 23 (2.4) 13.37 7.59–23.56
a Self-reported need for treatment was ascertained by asking the yes-or-no question: ‘Do you think you need treatment of some kind for sleeping diﬃculties?’
b Among those who reported a need for treatment, signiﬁcantly more women than men reported this variable (for descriptive statistics, see Table 1).
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3. Results
3.1. Self-reported need for treatment of sleeping diﬃculties
The study sample consisted of 1115 people who answered the
question: ‘Do you think you need treatment of some kind for sleep-
ing diﬃculties?’ A total of 139 (12.5%) participants reported a need
for treatment, and 976 (87.5%) reported no need for treatment of
sleeping diﬃculties.
3.2. Sociodemographic characteristics
As shown in Table 2, womenweremore likely thanmen to report
a need for treatment. A larger number of older (age 60–69 years)
than younger (age 18–29 years) people reported a need for treat-
ment. A higher proportion of people reported a need for treatment
whowere on sick leave, retired, or unemployed than those whowere
employed. The majority of the 33 people aged 60–69 years who re-
ported a need for treatment were retired from work (n = 23, 69.7%)
(data not shown in the table).
3.3. Sleep complaints
Table 2 shows that the sleep complaint most strongly associ-
ated with self-reported need for treatment of sleeping diﬃculties
was diﬃculty initiating sleep (OR 19.91), followed by nonrestorative
sleep (OR 16.41), early morning awakening (OR 6.03), and diﬃcul-
ty maintaining sleep (OR 5.97). Having a combination of two ormore
of these complaints increased the odds of reporting a need for treat-
ment (two sleep complaints, OR 6.63; three sleep complaints, OR
16.98; four sleep complaints, OR 23.71) (reference group: people
who reported one sleep complaint). Reporting persistent sleeping
diﬃculties (OR 17.71) and having insomnia disorder (OR 22.97) were
both associated with a need for treatment (Table 2). As shown in
Table 1, womenweremore likely thanmen to report a need for treat-
ment for insomnia disorder (OR 2.31, 95% CI 1.15–4.65).
3.4. Sleep duration and sleep onset latency
People who said they needed treatment for sleeping diﬃcul-
ties reported signiﬁcantly longer sleep onset latency (mean 57.45
minutes, SD 57.1, median 45 minutes) than those who reported no
need for treatment (mean 18.01 minutes, SD 22.4, median 10
minutes) (p < 0.001; data not shown). As shown in Fig. 1, those who
said they needed treatment reported shorter sleep duration onweek-
nights [t(149) = 9.053, p < 0.001] and weekends [t(145) = 4.935,
p < 0.001]. People slept about one hour longer on weekends than
weeknights, whether or not they reported a need for treatment.
Womenwho said they needed treatment weremore likely to extend
their sleep on weekends than men who said they needed treat-
ment [F(1958) = 6.39, p = 0.012].
Table 3
Odds ratios of the association between self-reported need for treatment by explanatory factors after stepwise inclusion of explanatory factors in three models.
Self-reported need for treatment by explanatory factors Model 1 Model 2 Model 3
OR (95% CI) OR (95% CI) OR (95% CI)
Sleep complaints Diﬃculty initiating sleep No 1 (Reference) 1 (Reference) 1 (Reference)
Yes 7.64 (4.64–12.60) 7.47 (4.46–12.52) 6.29 (3.67–10.78)
Early morning awakening No 1 (Reference)
Yes 1.29 (0.75–2.23)
Diﬃculty maintaining sleep No 1 (Reference) 1 (Reference) 1 (Reference)
Yes 2.06 (1.23–3.43) 1.78 (1.03–3.07) 1.52 (0.85–2.72)
Nonrestorative sleep No 1 (Reference) 1 (Reference) 1 (Reference)
Yes 6.77 (4.10–11.17) 3.67 (2.08–6.49) 3.70 (2.05–6.69)
Daytime symptoms Fatigue No 1 (Reference) 1 (Reference)
Yes 2.95 (1.54–5.65) 2.95 (1.53–5.68)
Depressed mood No 1 (Reference) 1 (Reference)
Yes 2.46 (1.08–5.57) 1.94 (0.85–4.42)
Easily irritated No 1 (Reference)
Yes 2.01 (0.84–4.80)
Diﬃculty concentrating No 1 (Reference)
Yes 1.65 (0.65–4.18)
Physical and mental disorders Mental health disorders No 1 (Reference)
Yes 3.01 (1.59–5.67)
Joint pain No 1 (Reference)
Yes 1.16 (0.64–2.10)
Gastrointestinal disorder No 1 (Reference)
Yes 1.07 (0.60–1.90)
Hypertension No 1 (Reference)
Yes 1.26 (0.64–2.47)
Asthma No 1 (Reference)
Yes 0.88 (0.45–1.74)
Heart disease No 1 (Reference)
Yes 1.54 (0.67–3.54)
Urogenital disorder No 1 (Reference)
Yes 1.73 (0.75–3.97)
Diabetes No 1 (Reference)
Yes 1.78 (0.72–4.42)
Fibromyalgia No 1 (Reference)
Yes 1.81 (0.50–6.54)
Sex Men 1 (Reference) 1 (Reference) 1 (Reference)
Women 0.84 (0.53–1.34) 7.12 (0.43–1.17) 0.67 (0.40–1.13)
Age Continuous variable 1.01 (0.10–1.03) 1.02 (1.01–1.03) 1.01 (0.10–1.03)
Hosmer–Lemeshow p-value 0.18 0.67 0.48
Abbreviations: 95% CI, conﬁdence interval; OR, odds ratio.
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3.5. Daytime symptoms
Participants who were fatigued (OR 12.36), had diﬃculty con-
centrating (OR 15.55), were easily irritated (OR 10.06), or had a
depressed mood (OR 11.58) had higher odds of reporting a need for
treatment for sleeping diﬃculties than those who did not have these
daytime symptoms (Table 2).
3.6. Interference with daily life
As shown in Table 2, those who reported a need for treatment
of sleeping diﬃculties were more likely than those who did not say
that sleeping diﬃculties were a problem in their daily lives (OR
70.87) or that sleeping diﬃculties interfered with their daily lives
(OR 37.41). As shown in Table 1, more women than men with self-
reported need for treatment said that sleeping diﬃculties were a
major problem in their lives (OR 2.33, 95% CI 1.16–4.69).
3.7. Health
As shown in Table 2, self-reported need for treatment of sleep-
ing diﬃculties was associated with poor general health (OR 13.37),
and with all mental and physical disorders except cancer. Of all the
disorders, mental health disorders (OR 9.79) and ﬁbromyalgia (OR
8.31) were most strongly associated with self-reported need for
treatment.
3.8. Help-seeking behavior and use of prescribed hypnotics
Of the survey respondents who reported a need for treatment
of sleeping diﬃculties, 69.8% had consulted a physician at some time
for help with sleeping diﬃculties, and 36.7% used prescribed hyp-
notics on a weekly basis.
Those who said that they needed treatment and used hypnot-
ics weekly (n = 51) reported diﬃculty initiating sleepmore frequently
than those who said they needed treatment and did not use hyp-
notics weekly (n = 88). However, this difference was not statistically
signiﬁcant (74.5% vs 58%, p = 0.050). There were no signiﬁcant dif-
ferences between early morning awakening (48% vs 37.9%, p = 0.250),
diﬃculty maintaining sleep (45.1% vs 42%, p = 0.726), or
nonrestorative sleep (64.6% vs 60.2%, p = 0.617). There were also no
signiﬁcant differences in sleep duration or sleep onset latency (results
not shown in the tables or ﬁgures).
3.9. Factors most strongly associated with self-reported need for
treatment
Logistic regression models (Table 3) were constructed to iden-
tify the factors most strongly associated with self-reported need for
treatment of sleeping diﬃculties. All models were adjusted for age
and sex.
Model 1 showed that three of the sleep complaints were sig-
niﬁcantly associated with self-reported need for treatment: diﬃculty
initiating sleep, nonrestorative sleep, and diﬃcultymaintaining sleep.
Diﬃculty initiating sleep was the most strongly associated factor.
In Model 2, daytime symptoms were added to the sleep com-
plaints that were signiﬁcant in Model 1. Diﬃculty initiating sleep
was the factor most strongly associated with self-reported need for
treatment. Nonrestorative sleep, diﬃculty maintaining sleep, fatigue,
depressed mood, and age were also signiﬁcantly associated with
need for treatment in this model.
In Model 3, physical and mental health disorders were added to
the sleep complaints and daytime symptoms that were signiﬁcant
in Model 2. This ﬁnal model showed that after taking other sleep
complaints, daytime symptoms, physical disorders, sex, and age into
account, the factor most strongly associated with self-reported need
for treatment of sleeping diﬃculties was diﬃculty initiating sleep.
Nonrestorative sleep, mental health disorders, and fatigue were also
signiﬁcantly associated with self-reported need for treatment.
3.10. Subgroup analysis of people with insomnia disorder who
reported no need for treatment
A total of 37.7% (n = 43) of those who met the DSM-V criteria for
insomnia disorder (n = 114) said that they did not need any treat-
ment for their sleeping diﬃculties. As shown in Fig. 2, of those with
insomnia, signiﬁcantly fewer (p < 0.05) who did not need treat-
ment than who did said they experienced diﬃculty initiating sleep,
nonrestorative sleep, daytime symptoms, persistent sleeping dif-
ﬁculties, poor general health, and/or mental health problems.
Moreover, fewer individuals, participants etc. experienced sleep-
ing diﬃculties as an overall problem in life (p < 0.05), reportedweekly
use of hypnotics (p < 0.05), and had consulted a physician because
of sleeping diﬃculties (p < 0.05).
People with insomnia who said that they did not need treat-
ment reported approximately one hourmore of sleep onweeknights
than those with insomnia who said that they did need treatment
[6.42 hours, SD 1.5 vs 5.38 hours, SD 1.6; t(108) = 3.394, p = 0.001];
these data are not shown in Fig. 2. Additionally, sleep onset latency
was shorter for people with insomnia who reported no need for
treatment (mean 49 minutes, SD 44.3, median 45 minutes) than for
those with insomnia who reported such a need (mean 72 minutes,
SD 70.5, median 60 minutes) (p = 0.039).
4. Discussion
4.1. Principal ﬁndings
This national study investigated self-reported need for treat-
ment of sleepingdiﬃculties in a representative sample of the Swedish
population. A total of 12.5% of the general population reported a need
for treatmentof sleepingdiﬃculties.Variouskindsof complaints about
sleep anddaytime symptomswere associatedwith this self-reported
need, aswerephysical andmental health disorders. After taking these
factors into account, the factor most strongly associated with self-
reported need for treatment of sleeping diﬃculties was diﬃculty
initiating sleep.Nonrestorative sleep, presence of amental health dis-
orders, and fatiguewere also important explanatory factors.Women
weremore likely thanmentoreportaneed for treatment.Morewomen
than men who reported a need for treatment had insomnia disor-
Fig. 1. Self-reported sleep duration on weeknights and weekends in those who re-
ported a need for treatment and no need for treatment of sleeping diﬃculties
(p < 0.05).
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der, andmorewomen thanmen perceived sleeping diﬃculties to be
a major problem in life.
4.2. Strengths and limitations
The major strength of the present study was the unique Scandi-
navian system of population-level data, which made it possible to
includea representative sampleof thegeneral population in the study.
Trained interviewers from Statistics Sweden conducted the tele-
phonesurvey.Theresponse ratewashigh, andageandsexdistributions
wereequal in the sample. Thematerial includedabroad rangeof ques-
tionsabout sleeppatterns,daytimesymptoms,andphysical andmental
health disorders. The speciﬁc daytime symptoms measured in the
present study are included in the diagnostic criteria for insomnia
drafted by the American Academy of SleepMedicine [19] and in the
International Classiﬁcation of Sleep Disorders [20].
Previous studies have focused on the characteristics of people
with sleeping diﬃculties who are in contact with healthcare ser-
vices, but many people with sleeping diﬃculties never seek help
[2,13–16]. The present study provided a new perspective on the need
for treatment of sleeping diﬃculties in a total population. All the
data analyzed were self-reported. However, this was not consid-
ered to be a limitation because sleeping diﬃculties and insomnia
are subjective in nature, and help-seeking behavior, diagnoses, and
treatment choices aremainly based on perceived complaints [18,20].
Because self-medication for sleeping diﬃculties is common [13],
a limitation of the study was the lack of survey questions about use
of over-the-counter medications (such as herbal medications and
melatonin) and alcohol. Furthermore, therewas no information about
sleep disorders such as sleep apnea or restless legs syndrome. Rest-
less legs syndrome is associated with diﬃculty initiating sleep [1].
The presence of this syndrome could have inﬂuenced people’s per-
ceived need for treatment and strengthened the association between
diﬃculty initiating sleep and self-reported need for treatment. Both
higher education [21] and higher socioeconomic status [14] predict
treatment-seeking for sleeping diﬃculties. Therefore, information
on these factors would have been salient to this study. Informa-
tion about other factors that may have inﬂuenced self-reported need
for treatment, such as physical activity, was also unavailable. Finally,
the survey data did not provide any information about the kind of
treatment people expected or wanted, or about strategies respon-
dents used to copewith sleeping diﬃculties or daytime impairments.
Information about these factors would have been a valuable com-
ponent of the results.
Sleep maintenance problems were assessed only by the number
of times people awoke at night; no information was available about
duration of awakening or the people’s experiences of awakening.
However, at least one study has shown that waking three or more
times per night (the present deﬁnition of problems with awaken-
ing) is related to daytime symptoms [22]. Additionally, in this study,
nonrestorative sleep was deﬁned as sleep that provided insuﬃ-
cient rest three or more nights a week during the past month. The
deﬁnition of nonrestorative sleep is inconsistent in the literature.
Both the present deﬁnition and ‘insuﬃcient sleep despite normal
sleep duration’ are common [23].
Finally, 1128 people responded to the survey, but 1115 respond
to the question about need for treatment. A total of 139 people re-
ported a need for treatment of sleeping diﬃculties, which may have
limited the statistical power of some of the estimates.
4.3. Being a woman
More women than men reported a need for treatment of sleep-
ing diﬃculties. Studies have shown that, in general, women report
more sleep complaints than men [4]. In this study, a signiﬁcantly
higher proportion of women than men who reported a need for
treatment met the criteria for insomnia disorder and said that sleep-
ing diﬃculties were a major problem in their lives. Among those
who reported a need for treatment, there was a greater discrep-
ancy between weeknight sleep and weekend sleep in women than
in men. One study has found that women’s healthcare visits for in-
somnia peak around the menopausal transitional period [24]. In the
current analyses, however, women’s self-reported need for treat-
ment did not peak in the menopausal transition period (assumed
to be between the ages of 40 and 59).
4.4. Age
Participants aged 60–69 years had a higher prevalence of sleep-
ing diﬃculties than younger participants. The majority of these
people were retired, an age group which was associated with self-
reported need for treatment of sleeping diﬃculties in this study.
Fig. 2. Differences between people with insomnia disorder who reported no need for treatment of sleeping diﬃculties (n = 43) and those who reported a need for treat-
ment of sleeping diﬃculties (n = 71). All differences shown are statistically signiﬁcant (p < 0.05).
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Sleeping diﬃculties are common in older people (mean age ap-
proximately 70 years), whereas insomnia disorder is most common
in younger people (aged 40–49 years) [25].
4.5. Sleep complaints
The present results suggested that diﬃculty initiating sleep has
a greater impact on the need for treatment than other sleep com-
plaints such as early morning awakening and diﬃculty maintaining
sleep. This result is in line with the results of previous studies. Earlier
studies have found that diﬃculty initiating sleep is more persis-
tent than other sleep complaints [15], and that people who have
diﬃculty initiating sleep are less satisﬁed with their sleep and have
shorter sleep duration than people with other sleep complaints [26].
Furthermore, diﬃculty initiating sleep is strongly associated with
depression [27] and anxiety [1,28]. Those who report diﬃculty ini-
tiating sleep are more prone to use hypnotics than people with other
sleep complaints [1].
The present study found that nonrestorative sleep was associ-
ated with self-reported need for treatment. This ﬁnding is consistent
with those of previous research, which indicate that nonrestorative
sleep can have a variety of serious consequences. For instance, a large
survey of a representative sample of people from seven countries
in Europe found that nonrestorative sleep caused more severe
daytime symptoms than diﬃculty initiating or maintaining sleep.
The survey also revealed . . . that nonrestorative sleep was associ-
atedwith increased sleep onset latency and that peoplewho reported
nonrestorative sleep hadmore healthcare consultations than people
with insomnia disorder [29] .
4.6. Sleep onset latency and sleep duration
People who reported a need for treatment of sleeping diﬃcul-
ties reported a sleep onset latency of almost one hour and short sleep
duration (approximately six hours on weeknights). On weekends,
they slept one hour longer than on. It is reasoned that stress and
worry about potential daytime impairment the following workday
may lead people to try harder to fall asleep. This increased effort
then leads to increased arousal, which in turn decreases the per-
son’s ability to sleep on weeknights. This process has been described
by Espie et al. as the attention–intention–effort pathway [30].
4.7. Daytime symptoms
Daytime symptoms were prevalent in people who reported a
need for treatment, which is in line with existing literature about
predictors of help-seeking. The experience of daytime symptoms,
not sleep disturbance, seems to be themain reason for seeking treat-
ment [31,32]. However, in the present study, it was found that
diﬃculty initiating sleep and nonrestorative sleepweremore strongly
associated with reported need for treatment than were daytime
symptoms, although fatigue was also a signiﬁcant explanatory factor.
A strong association was found between experiencing sleeping
diﬃculties as a pervasive problem in life and reporting a need for
treatment. The interpretation of this ﬁnding is that when sleeping
diﬃculties interfere with life in a broad sense, people feel the need
for help and treatment. This result might reﬂect the 24-hour per-
petuating process that maintains insomnia. This process is a vicious
circle of worry, arousal, selective attention, and safety behaviors in-
tended to cope with the consequences of insomnia and to promote
sleep [33]. Dysfunctional coping that interferes with daily life may
make people feel that sleeping diﬃculties are a major problem in
life.
4.8. Health problems
This study found associations between self-reported need for
treatment of sleeping diﬃculties and poor general health, and
between the need for treatment of physical and most particularly,
mental health disorders. These results are consistent with the results
of previous epidemiological research, which found that sleeping dif-
ﬁculties are related to depression and other mental health disorders
[7], poor health [7], cardiovascular disease [6], and diabetes [34].
4.9. Help-seeking behavior and self-reported need for treatment: use
of prescribed hypnotics
It was found that 70% of all participants who reported a need
for treatment of sleeping diﬃculties had consulted a physician for
their sleeping diﬃculties at some point. This ﬁnding is in line with
the ﬁndings of other studies that show that sleeping diﬃculties tend
to persist over time [35,36]. Several previous studies have exam-
ined the characteristics of people who consult primary healthcare
for sleeping diﬃculties. Such people report co-occurring somatic
[21] or mental health disorders [26], psychological distress [2], and
physical discomfort [2]. Furthermore, they report daytime sleepi-
ness [37], fatigue [2], short sleep duration [21,37], and are of older
age (age 25–64) [37]. These characteristics correspond to factors that
were associated with the need for treatment of sleeping diﬃcul-
ties in this study. The new information that this study adds, however,
is the strength of the association between diﬃculty initiating sleep
and the need for treatment.
It was found that 30% of the participants who reported a need
for treatment also said that they had never consulted a physician
for help with their sleeping diﬃculties. The incidence rate of health-
care seeking for sleeping diﬃculties was much lower than the
estimated prevalence of sleeping diﬃculties in other populations
[24]. Previous studies have described the tendency not to seek help
for sleeping diﬃculties. One longitudinal study that followed 474
people with sleeping diﬃculties for one year found that 72% did not
seek any consultation during that year. A total of 66% of the people
in the longitudinal study still had sleeping diﬃculties at follow-
up [15]. Studies have found possible barriers to seeking help. Some
people who have sleeping diﬃculties do not seek healthcare because
they feel they are not understood by healthcare practitioners [38]
and because they do not understand the available treatment options
[13,38]. Other barriers to seeking help include the perception that
insomnia is not a real problem and is something that people should
be able to manage alone [17], a belief that hypnotics are the only
treatment option [13,17], and a reluctance to take medication [17].
It is reasoned that people with both sleeping diﬃculties and other
health problems probably seek healthcare primarily in connec-
tion with their other health problems, and that their sleeping
diﬃculties might be identiﬁed and treated as a result of these con-
sultations. The threshold for seeking a consultation, and therefore
for obtaining treatment, might be higher for those who perceive
sleeping diﬃculties as their only health problem.
In the present study, 36.7% of thosewho reported a need for treat-
ment were being treatedwith hypnotics. Among those who said they
needed treatment, those who were and who were not being treated
with hypnotics reported similar sleep complaints. In fact, more of
those whowere being treated with hypnotics reported diﬃculty ini-
tiating sleep than those not being treated with hypnotics, although
this result was not statistically signiﬁcant (p = 0.05).
Studies have shown that cognitive behavioral therapy for in-
somnia reduces sleeping diﬃculties, especially diﬃculty initiating
sleep, and that gains are durable [39,40]. Cognitive behavioral therapy
for insomnia may also be more effective at decreasing diﬃculty ini-
tiating sleep than treatment with hypnotics, even in the short term
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[41]. Nevertheless, this is not a treatment option that is widely avail-
able to patients [42].
4.10. People with insomnia disorder who reported no need for
treatment
In the present study, more than one third of those identiﬁed with
insomnia disorder said that they did not need any treatment for their
sleeping diﬃculties. The present results suggest these people may
have been able tomanage their insomnia because their mental health
was stable and because they experienced fewer daytime symp-
toms than those with insomnia who reported a need for treatment.
Furthermore, their weeknight sleep duration was moderate (ap-
proximately 6.5 hours). An earlier study has shown that sleeping
less than 6.5 hours a night predicts help-seeking behaviors [37].
5. Conclusions
Many people in the general Swedish population reported a need
for treatment of sleeping diﬃculties, which is a ﬁnding that con-
ﬁrms that sleeping diﬃculties are a public health issue. The results
of this study contribute to the understanding of factors that may
explain the need for treatment of sleeping diﬃculties, which is val-
uable information in clinical consultations.
Various kinds of sleep complaints, daytime symptoms, and phys-
ical and mental health disorders were associated with self-reported
need for treatment of sleeping diﬃculties. These factors have also
been associated with help-seeking for sleeping diﬃculties in pre-
vious studies. A notable ﬁnding of the present study was the strong
association between diﬃculty initiating sleep and self-reported need
for treatment, an association that persisted even after taking other
explanatory factors into account. Nonrestorative sleep, mental health
disorders, and fatigue were also signiﬁcantly associated with the
need for treatment. Morewomen thanmen reported a need for treat-
ment, and the transition period from employment to retirement in
people aged 60–69 years was a time when many people reported
a need for treatment. A total of 36.7% of those who reported a need
for treatment were being treated with hypnotics, a phenomenon
that deserves further attention. Stable mental health, moderate
daytime symptoms, andmoderate sleep durationmay create a sense
of manageability that makes people feel that they do not need treat-
ment despite sleeping diﬃculties and daytime impairments (ie,
insomnia disorder).
The considerable self-reported need for treatment in the general
population and the ﬁnding that 30% of people who felt that they
needed treatment did not consult a healthcare provider about their
problem implies a need for increased public and clinical aware-
ness of the impact of sleeping diﬃculties in daily life and on health.
Additionally, better knowledge about and access to the full range
of currently available treatments for reducing sleep onset latency
might contribute to public health. Thus, it seems reasonable to in-
crease the availability of treatments that target diﬃculty initiating
sleep, such as cognitive behavioral therapy for insomnia, and to in-
crease public awareness of such treatment options.
The present study also suggested that further research on the
kinds of treatment the population expects and wants is war-
ranted. Additionally, qualitative interviews with people who report
diﬃculty initiating sleep may help to understand why diﬃculty ini-
tiating sleep has such an impact on the need for treatment.
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